Accelevation
ACCV

Accelevation (ACCV) analyst forecast and price target

Analyst forecast

Buy

Consensus of 7 analyst ratings

Buy
6
Hold
1
Sell
0
Average price target
$19.20+73.13% vs. last price
Last $11.09
Low $16.00High $22.00

Based on 5 analyst targets

7 firms have rated Accelevation Holdings (ACCV) in the last 3 months: 6 buy, 1 hold and 0 sell. Their average 12-month price target is $19.20, 72.6% above a share price of $11.13, ranging from $16 (Baird) to $22 (Goldman Sachs). No firm has changed its rating in that time.

Recent analyst ratings

Last 3 months
FirmActionRatingPrice targetDate
JP MorganInitiated CoverageOverweight$20.00Oct 26, 2026
BairdInitiated CoverageOutperform$16.00Oct 26, 2026
Wolfe ResearchInitiated CoverageOutperform—Oct 26, 2026
Goldman SachsInitiated CoverageBuy$22.00Oct 26, 2026
Morgan StanleyInitiated CoverageEqual-Weight$18.00Oct 26, 2026
BarclaysInitiated CoverageOverweight$20.00Oct 26, 2026
William BlairInitiated CoverageOutperform—Oct 26, 2026

Frequently asked questions

  • What is the price target for ACCV stock?

    The average 12-month analyst price target for Accelevation (ACCV) is $19.20, with a high estimate of $22.00 and a low of $16.00, across 5 analysts.

  • Is ACCV a buy, sell, or hold?

    Analysts covering Accelevation currently average a Buy rating: 6 buy, 1 hold and 0 sell, from 7 analysts. Ratings reflect analyst opinion, not investment advice.

  • What upside do analysts see for ACCV?

    The average price target of $19.20 implies 73.13% upside from the last price of $11.09.

  • Who has the highest and lowest price target for ACCV?

    Among the price targets analysts have published for Accelevation in the last 3 months, the highest is $22.00 from Goldman Sachs and the lowest is $16.00 from Baird.

  • Has ACCV been upgraded or downgraded recently?

    No. Accelevation has had no analyst upgrades or downgrades in the last 3 months.

  • What is the latest analyst rating on ACCV?

    On Oct 26, 2026, JP Morgan initiated coverage of Accelevation at Overweight with a price target of $20.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.